Neuprex recombinant bactericidal/permeability-increasing protein data

XOMA (Berkeley, Calif.) announced results of a Phase I/II cross-over trial in normal volunteers given small

Read the full 160 word article

How to gain access

Continue reading with a
two-week free trial.